Dr. Tian Wang

Biography

Tian Wang is a Conjoint Senior Lecturer at the University of New South Wales and a Postdoctoral Research Fellow at the George Institute for Global Health. His research primarily focuses on cardiovascular disease, hypertension management, and nutrition, employing a multidisciplinary approach to improve cardiometabolic outcomes through both pharmaceutical strategies, such as single-pill combination therapy, and non-pharmaceutical strategies, including nutrition interventions. Dr. Wang leads the national evaluation of Australia’s 60-day dispensing policy for antihypertensive medicines and conducts post-hoc analyses of the GMRx2 international trials, which examine the effects of antihypertensives on blood pressure variability—a novel marker of cardiovascular risk. His work has been published in leading journals such as the European Heart Journal and JAMA Network Open, accumulating 340 citations over 4.5 years of research. Dr. Wang has secured $190,000 in research funding and has presented his findings at 14 national and international conferences, earning multiple awards and recognition as a finalist for the 2025 Cardiac Society of Australia and New Zealand Conference prize. In addition to his research, he is involved in teaching, curriculum development, and supervision at UNSW and the University of Sydney. Dr. Wang is committed to equity, capacity building, and leadership development for early-career researchers and serves on national committees for Hypertension Australia and the Nutrition Society of Australia.

Research Interests